Home Nucleus Pharmaceuticals U.K. Liver Fibrosis Treatment Market to 2032

U.K. Liver Fibrosis Treatment Market to 2032

Overview

The U.K. Liver Fibrosis Treatment Market is expected to reach a 1,070.04 USD Million by 2032 and is projected to grow at a CAGR of 10.14% from 2025 to 2032.

Revenue, 2024 (USD Million)
495.60
Forecast, 2032 (USD Million)
1,070.04
CAGR, 2024 - 2032
10.14%
Report Coverage
U.K.

U.K. Liver Fibrosis Treatment Market 2018-2032 USD Million

U.K. Liver Fibrosis Treatment Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 495.60 USD Million
  • Projected Market Size (2032): 1,070.04 USD Million
  • CAGR (2025-2032): 10.14%

Key Findings of U.K. Liver Fibrosis Treatment Market

  • The U.K. Liver Fibrosis Treatment Market was valued at 495.60 USD Million in 2024.
  • The U.K. Liver Fibrosis Treatment Market is likely to grow at a CAGR of 10.14% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Medication in Treatment Type Segment accounted for the largest share of the market with a revenue of 409.04 USD Million
  • The fastest growing segment F2 in Stages Segment grew Fastest with a CAGR of 11.89% during the forecast period from 2024 to 2032.

U.K. Liver Fibrosis Treatment Market Scope

U.K. Liver Fibrosis Treatment Market Segmentation & Scope
Gender
  • Female
  • Male
End User
  • Others
  • Ambulatory and Research Centers
  • Clinics
  • Specialty Clinics
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Indication
  • Others
  • Genetic Disorders
  • Autoimmune Liver Diseases
  • Alcoholic Liver Disease (ALD)
  • Hepatitis B & C-Induced Fibrosis
  • Non-Alcoholic Steatohepatitis (NASH)
Treatment Type
  • Surgery/Therapy
  • Medication
Stages
  • F4
  • F3
  • F1
  • F2

U.K. Liver Fibrosis Treatment Market Data Coverage Insights

Study Period 2024-2032
Base Year 2024
Unit Revenue in USD Million
Market Value in 2024 495.60 USD Million
Market Value in 2032 1,070.04 USD Million
CAGR (2025-2032) 10.14%
Historic Data 2016-2023
Market Segments Covered Gender,End User,Distribution Channel,Indication,Treatment Type,Stages

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 495.60 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 495.60 USD Million in 2024.

Segments and Scope

  • U.K. Liver Fibrosis Treatment Market to 2032, By Gender
    • Male is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 316.59 USD Million in the year 2024.
    • Male is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.67 % in forecast period 2025-2032.
  • U.K. Liver Fibrosis Treatment Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 247.52 USD Million in the year 2024.
    • Specialty Clinics is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.28 % in forecast period 2025-2032.
  • U.K. Liver Fibrosis Treatment Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 355.80 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.51 % in forecast period 2025-2032.
  • U.K. Liver Fibrosis Treatment Market to 2032, By Indication
    • Non-Alcoholic Steatohepatitis (NASH) is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 176.25 USD Million in the year 2024.
    • Non-Alcoholic Steatohepatitis (NASH) is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 11.40 % in forecast period 2025-2032.
  • U.K. Liver Fibrosis Treatment Market to 2032, By Treatment Type
    • Medication is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 409.04 USD Million in the year 2024.
    • Medication is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 10.30 % in forecast period 2025-2032.
  • U.K. Liver Fibrosis Treatment Market to 2032, By Stages
    • F2 is the largest segment in U.K. Liver Fibrosis Treatment Market to 2032 with a revenue of 166.25 USD Million in the year 2024.
    • F2 is the Fastest growing segment in U.K. Liver Fibrosis Treatment Market to 2032 with a Growth rate of 11.89 % in forecast period 2025-2032.

U.K. Liver Fibrosis Treatment Market Company Share Analysis

 
Company Name Company Share Analysis
Merck & Co., Inc.
Novartis AG
AbbVie Inc.
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
U.K. Liver Fibrosis Treatment Market Company Share Analysis

U.K. Liver Fibrosis Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Liver Fibrosis Treatment Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Liver Fibrosis Treatment Market Company Profiling

U.K. Liver Fibrosis Treatment Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.K. Liver Fibrosis Treatment Market is segmented based on Segmentation Gender,End User,Distribution Channel,Indication,Treatment Type,Stages.
U.K. Liver Fibrosis Treatment Market was valued at USD 495.60(Revenue in USD Million) in 2024.
U.K. Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.14% during the forecast period of 2024 to 2032.
The Medication segment is expected to dominate the U.K. Liver Fibrosis Treatment Market, holding a largest market share of 409.04 USD Million in 2024

U.K. Liver Fibrosis Treatment Market Scope

U.K. Liver Fibrosis Treatment Market Segmentation & Scope
Gender
  • Female
  • Male
End User
  • Others
  • Ambulatory and Research Centers
  • Clinics
  • Specialty Clinics
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Indication
  • Others
  • Genetic Disorders
  • Autoimmune Liver Diseases
  • Alcoholic Liver Disease (ALD)
  • Hepatitis B & C-Induced Fibrosis
  • Non-Alcoholic Steatohepatitis (NASH)
Treatment Type
  • Surgery/Therapy
  • Medication
Stages
  • F4
  • F3
  • F1
  • F2
Frequently Asked Questions
The U.K. Liver Fibrosis Treatment Market is segmented based on Segmentation Gender,End User,Distribution Channel,Indication,Treatment Type,Stages.
U.K. Liver Fibrosis Treatment Market was valued at USD 495.60(Revenue in USD Million) in 2024.
U.K. Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.14% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Liver Fibrosis Treatment Market for final year is USD 1,070.04 (USD Million).

U.K. Liver Fibrosis Treatment Market Company Profiling

U.K. Liver Fibrosis Treatment Market Company Profiling
Frequently Asked Questions
The U.K. Liver Fibrosis Treatment Market is segmented based on Segmentation Gender,End User,Distribution Channel,Indication,Treatment Type,Stages.
U.K. Liver Fibrosis Treatment Market was valued at USD 495.60(Revenue in USD Million) in 2024.
U.K. Liver Fibrosis Treatment Market is projected to grow at a CAGR of 10.14% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Liver Fibrosis Treatment Market for final year is USD 1,070.04 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES